Vasoactive Intestinal Peptide (Vip) (Middle Region) Peptid
Kurzübersicht für Vasoactive Intestinal Peptide (Vip) (Middle Region) Peptid (ABIN8115684)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- VIP Peptide - middle region
-
Sequenz
- VPVKRHSDAV FTDNYTRLRK QMAVKKYLNS ILNGKRSSEG ESPDFPEELE
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-VIP Antibody(ARP45465_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- Vip (Vasoactive Intestinal Peptide (Vip))
-
Hintergrund
-
Background Information: The protein encoded by this gene belongs to the glucagon family. It stimulates myocardial contractility, causes vasodilation, increases glycogenolysis, lowers arterial blood pressure and relaxes the smooth muscle of trachea, stomach and gall bladder. Alternative splicing occurs at this locus and two transcript variants encoding distinct isoforms have been identified.
Alternative Symbols: MGC13587, PHM27
-
Molekulargewicht
- 3kDa
-
Gen-ID
- 7432
-
NCBI Accession
- NP_003372
-
UniProt
- P01282
Target
-